GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » Sale Of Investment

Dae Hwa Pharm Co (XKRX:067080) Sale Of Investment : ₩13,736 Mil (TTM As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co Sale Of Investment?

Dae Hwa Pharm Co's sale of investment for the three months ended in Dec. 2024 was ₩2,745 Mil. It means Dae Hwa Pharm Co gained ₩2,745 Mil from selling investments. Dae Hwa Pharm Co's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was ₩13,736 Mil.

Compared with last quarter (₩983 Mil in Sep. 2024 ), Dae Hwa Pharm Co gained more money from selling investments in Dec. 2024 (₩2,745 Mil).


Dae Hwa Pharm Co Sale Of Investment Historical Data

The historical data trend for Dae Hwa Pharm Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co Sale Of Investment Chart

Dae Hwa Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,865.23 14,854.60 19,931.77 7,495.31 13,736.21

Dae Hwa Pharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,944.35 3,507.06 6,500.49 983.19 2,745.46

Dae Hwa Pharm Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩13,736 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dae Hwa Pharm Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Dae Hwa Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804
Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co Headlines

No Headlines